IL156798A0 - Use of flumazenil in developing a drug for the treatment of alcohol dependency - Google Patents

Use of flumazenil in developing a drug for the treatment of alcohol dependency

Info

Publication number
IL156798A0
IL156798A0 IL15679802A IL15679802A IL156798A0 IL 156798 A0 IL156798 A0 IL 156798A0 IL 15679802 A IL15679802 A IL 15679802A IL 15679802 A IL15679802 A IL 15679802A IL 156798 A0 IL156798 A0 IL 156798A0
Authority
IL
Israel
Prior art keywords
flumazenil
developing
drug
treatment
alcohol dependency
Prior art date
Application number
IL15679802A
Other languages
English (en)
Original Assignee
Hythiam Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hythiam Inc filed Critical Hythiam Inc
Publication of IL156798A0 publication Critical patent/IL156798A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
IL15679802A 2001-01-17 2002-01-10 Use of flumazenil in developing a drug for the treatment of alcohol dependency IL156798A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200100106 2001-01-17
PCT/ES2002/000008 WO2002056964A1 (es) 2001-01-17 2002-01-10 Empleo de flumazenilo en la elaboración de una medicación para el tratamiento de la dependencia de alcohol

Publications (1)

Publication Number Publication Date
IL156798A0 true IL156798A0 (en) 2004-02-08

Family

ID=8496426

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15679802A IL156798A0 (en) 2001-01-17 2002-01-10 Use of flumazenil in developing a drug for the treatment of alcohol dependency

Country Status (23)

Country Link
US (2) US7348321B2 (pt)
EP (1) EP1374952B1 (pt)
JP (2) JP2004519461A (pt)
KR (1) KR100712570B1 (pt)
CN (1) CN1486205A (pt)
AT (1) ATE338575T1 (pt)
AU (1) AU2002226427B2 (pt)
BR (1) BR0206549A (pt)
CA (1) CA2433833C (pt)
CR (1) CR7049A (pt)
CY (1) CY1107500T1 (pt)
DE (1) DE60214527T2 (pt)
DK (1) DK1374952T3 (pt)
ES (1) ES2269661T3 (pt)
HK (1) HK1061661A1 (pt)
IL (1) IL156798A0 (pt)
MX (1) MXPA03006411A (pt)
NZ (2) NZ527583A (pt)
PT (1) PT1374952E (pt)
RU (1) RU2300378C2 (pt)
UA (1) UA78199C2 (pt)
WO (1) WO2002056964A1 (pt)
ZA (1) ZA200305922B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192271A1 (en) 2003-07-15 2005-09-01 Hythiam, Inc. Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse
US20060172998A1 (en) * 2005-02-03 2006-08-03 Halikas James A Method of preventing relapse in the abstinent substance dependent individual
US20060172996A1 (en) * 2005-02-03 2006-08-03 Halikas James A Method of preventing relapse in the abstinent substance dependent individual
EP1868593A2 (en) * 2005-04-07 2007-12-26 Hythiam, Inc. Improved methods of and compositions for the prevention of anxiety, substance abuse, and dependence
US20060263304A1 (en) * 2005-05-23 2006-11-23 Halikas James A Method of controlling alcohol intake and reversing alcohol effects
SG183696A1 (en) * 2007-08-06 2012-09-27 Biotie Therapies Inc Medicaments comprising nepicastat for use in treating dependence on a substance
EP2186517A4 (en) * 2007-08-08 2010-08-18 Ibanez Juan Jose Legarda USE AND METHODS OF USING A SEROTONIN3 (5-HT3) RECEPTOR ANTAGONIST AND CHLORIDE CHANNEL MODULATOR FOR THE TREATMENT OF DRUG OR DRUG ADDICTION OR DEPENDENCE OR CENTER NERVOUS DISORDERS
AU2010215075B2 (en) * 2009-02-20 2015-08-20 Palmaya Pty Ltd Pharmaceutical preparation and delivery system
US8930050B2 (en) * 2009-04-29 2015-01-06 Marine Canada Acquisition Inc. Method and system for increasing or decreasing engine throttle in a marine vessel
US20100280684A1 (en) * 2009-04-29 2010-11-04 Pierre Garon Synchronization of shift and throttle controls in a marine vessel
US8347859B2 (en) * 2009-04-29 2013-01-08 Marine Canada Acquisition Inc. Automatic throttle calibration in a marine vessel
US8387589B2 (en) * 2009-04-29 2013-03-05 Marine Canada Acqusition Inc. Position sensor for an output shaft used in a shift and throttle system
US8406944B2 (en) * 2010-02-10 2013-03-26 Pierre Garon Control system and method for starting and stopping marine engines
US8845490B2 (en) 2010-02-10 2014-09-30 Marine Canada Acquisition Inc. Method and system for delaying shift and throttle commands based on engine speed in a marine vessel
US8182396B2 (en) * 2010-02-10 2012-05-22 Marine Canada Acquisition In.c Method and system for delaying shift and throttle commands based on engine speed in a marine vessel
AU2012221704B2 (en) 2011-02-23 2013-12-05 Coeruleus Ltd. Flumazenil complexes, compositions comprising same and uses thereof
RU2468799C1 (ru) * 2011-08-03 2012-12-10 Общество с ограниченной ответственностью "Урал Крафт" Способ купирования алкогольного абстинентного синдрома посредством блокады бензодиазепиновых рецепторов

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519017A (en) * 1990-03-29 1996-05-21 Lts Lohmann Therapie-Systeme Gmbh + Co. Kg Pharmaceutic formulation for the treatment of alcoholism
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use
GB9420010D0 (en) 1994-10-01 1994-11-16 Marck Sharp & Dohme Limited Nucleic acids
US20030176456A1 (en) * 2001-12-21 2003-09-18 June Harry L. Methods for reducing alcohol cravings in chronic alcoholics
US6740677B2 (en) 2002-08-19 2004-05-25 Hong Xue Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2′ hydroxyflavonoids

Also Published As

Publication number Publication date
HK1061661A1 (en) 2004-09-30
NZ539400A (en) 2006-04-28
DE60214527D1 (de) 2006-10-19
RU2300378C2 (ru) 2007-06-10
AU2002226427B2 (en) 2006-11-16
PT1374952E (pt) 2006-12-29
NZ527583A (en) 2006-03-31
MXPA03006411A (es) 2004-12-02
CR7049A (es) 2008-02-20
BR0206549A (pt) 2004-02-25
ATE338575T1 (de) 2006-09-15
KR100712570B1 (ko) 2007-05-02
DK1374952T3 (da) 2007-01-02
CY1107500T1 (el) 2013-03-13
EP1374952A1 (en) 2004-01-02
US20040092509A1 (en) 2004-05-13
ES2269661T3 (es) 2007-04-01
JP2004519461A (ja) 2004-07-02
EP1374952B1 (en) 2006-09-06
ZA200305922B (en) 2004-08-02
JP2008201796A (ja) 2008-09-04
CN1486205A (zh) 2004-03-31
KR20040020046A (ko) 2004-03-06
UA78199C2 (en) 2007-03-15
RU2003125274A (ru) 2005-01-20
US20080132492A1 (en) 2008-06-05
DE60214527T2 (de) 2007-04-05
US7348321B2 (en) 2008-03-25
CA2433833A1 (en) 2002-07-25
CA2433833C (en) 2009-06-02
WO2002056964A1 (es) 2002-07-25

Similar Documents

Publication Publication Date Title
CY1107500T1 (el) Η χρηση του φλουμαζενιλ στην αναπτυξη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της εξαρτησης απο το αλκοολ
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
CY1106845T1 (el) Χρηση της φλουμαζενιλης για την παρασκευη ενος φαρμακου για την αγωγη της εξαρτησεως απο την κοκαϊνη
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
BR0015974A (pt) Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
PT913156E (pt) Utilizacao de proteina c activada para tratar estados hipercoagulaveis associados com sepsia
ATE359077T1 (de) Orale gabe von 6-hydroxy-oxymorphon als analgetikum
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
NO20042208L (no) Vaginalt administrerte anti-dysrytmiske midler for behandling av bekkensmerter
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
EE200100689A (et) IL6RIL6 kimääri kasutamine ravimi valmistamiseks,mis on ette nähtud neuroloogiliste haiguste ravimiseks, ning farmatseutiline kompositsioon
SE0004827D0 (sv) Therapeutic compounds
DK1492539T3 (da) Statin-terapi til forögelse af kognitiv funktion
AR015537A1 (es) Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina.
BR0211323A (pt) Combinação de ingredientes ativos, uso de uma combinação de ingredientes ativos e método de terapia farmacológica de dependência de nicotina
WO2001060278A3 (en) Oral therapeutic delivery appliance
ATE337790T1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
BR0314364A (pt) Uso de inibidores de pde iv para tratar angiogênese
DK0872239T3 (da) Anvendelse af olanzapin til fremstilling af et lægemiddel til behandling af cerebral fokal iskæmi
SE9803623D0 (sv) New therapeutic application
UA36361A (uk) Спосіб лікування захворювань щитовидної залози
PT872238E (pt) Utilizacao de olanzapina para o fabrico de um medicamento para neuroproteccao
RS49796B (sr) UPOTREBA SOLI 3α, 7α-DIHIDROKSI-12-KETO-5β-HOLANSKE KISELINE KAO AKTIVNE SUPSTANCE ZA IZRADU LEKOVA ZA LEČENJE DIJABETESA